Travere Therapeutics (TVTX) Change in Inventory (2014 - 2026)
Travere Therapeutics (TVTX) posted Change in Inventory of $742000.0 for Q1 2026, up 163.04% on a QoQ basis from -$1.2 million in Q4 2025, and up 120.25% year-over-year from $336888.2 in Q1 2025.
Travere Therapeutics (TVTX) Change in Inventory (2014 - 2026) Analysis & Trends
Travere Therapeutics' Change in Inventory history runs 13 years deep, the most recent figure standing at $742000.0 for Q1 2026.
- Quarterly Change in Inventory rose 120.25% year-over-year to $742000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$610000.0 (up 64.47% YoY) and the FY2025 annual result came in at -$5.0 million, down 233.02% from the prior year.
- Change in Inventory was $742000.0 for Q1 2026 at Travere Therapeutics, up from -$1.2 million in the prior quarter.
- Across five years, Change in Inventory topped out at $22.4 million in Q4 2023 and bottomed at -$3.7 million in Q1 2025.
- A 5-year average of $2.4 million and a median of $285000.0 in 2024 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2023 — Change in Inventory soared 59028.95% — and 2025, when it slumped 512.98%.
- Travere Therapeutics' Change in Inventory stood at -$38000.0 in 2022, then surged by 59028.95% to $22.4 million in 2023, then slumped by 98.73% to $285000.0 in 2024, then slumped by 512.98% to -$1.2 million in 2025, then surged by 163.04% to $742000.0 in 2026.
- Business Quant data shows TVTX's Change in Inventory at $742000.0 in Q1 2026, -$1.2 million in Q4 2025, and -$194000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 71.84 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Travere Therapeutics | 5.21 Bn | 5.21 Bn | 125.25 Mn | 742,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 742,000.00 |
| Mar 31, 2026 | 742,000.00 |
| Dec 31, 2025 | -1.18 Mn |
| Dec 31, 2025 | -1.18 Mn |
| Sep 30, 2025 | -194,000.00 |
| Sep 30, 2025 | -194,000.00 |
| Jun 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 19,000.00 |
| Mar 31, 2025 | -3.66 Mn |
| Mar 31, 2025 | -3.66 Mn |
| Dec 31, 2024 | 285,000.00 |
| Dec 31, 2024 | 285,000.00 |
| Sep 30, 2024 | 246,000.00 |
| Sep 30, 2024 | 246,000.00 |
| Jun 30, 2024 | 1.42 Mn |
| Jun 30, 2024 | 1.42 Mn |
| Mar 31, 2024 | 1.82 Mn |
| Mar 31, 2024 | 1.82 Mn |
| Dec 31, 2023 | 22.39 Mn |
| Dec 31, 2023 | 22.39 Mn |